WaveMan
WaveMan · Company
PLUR · Pluri Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

PLUR Pluri (PLUR) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Biological products, (no diagnostic substances) · CIK 0001158780
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
5
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $0 priced

Pluri insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Pluri Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Manieu Alexandre Weinstein
Director
BUY
2026-10-27 SECtraded 2026-10-23
833,334
$1.3M
n/a
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Apr 28, 2025.
  • The trade is 40.0% of the 2,083,334 shares held after it.
  • No other insider bought within 30 days.
  • 5 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Manieu Alexandre Weinstein bought about $1.3M of PLUR on Oct 23, 2026, the largest insider purchase at the company since 2025; 5 funds added in the latest 13F quarter.
Chutzpah Holdings Ltd
Director
BUY
2025-07-01 SECtraded 2025-04-28
523,437
$2.4M
-81.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 56.2% of the 931,246 shares held after it.
  • 1 other insider bought within 30 days.
  • 5 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Chutzpah Holdings Ltd bought about $2.4M of PLUR on Apr 28, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 5 funds added in the latest 13F quarter.
Chutzpah Holdings Ltd
Director
BUY
2025-07-01 SECtraded 2025-04-28
452,702
$2.1M
-81.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 452,702 shares held after it.
  • 1 other insider bought within 30 days.
  • 5 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Chutzpah Holdings Ltd bought about $2.1M of PLUR on Apr 28, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 5 funds added in the latest 13F quarter.
Manieu Alexandre Weinstein
Director
BUY
2025-11-20 SECtraded 2025-04-28
452,702
$2.1M
-73.9%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 452,702 shares held after it.
  • 1 other insider bought within 30 days.
  • 5 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Manieu Alexandre Weinstein bought about $2.1M of PLUR on Apr 28, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 5 funds added in the latest 13F quarter.
Aberman Zami
Director
SELL
2022-12-22 SECtraded 2022-12-20
2,000
$1.9K
-87.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.1% of the 1,491,973 shares held after it.
  • No other insider sold within 30 days.
  • 5 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Aberman Zami sold about $1.9K of PLUR on Dec 20, 2022, the largest insider sale at the company on our record; 5 funds added in the latest 13F quarter.
5 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
5 funds bought in last quarter
below 95% of Pharma & Biotech
Revenue
-24.0% year over year
below 71% of Pharma & Biotech
Margin
-2344.6% net margin
below 93% of Pharma & Biotech
Buybacks
no share repurchases reported
Short interest
0.3% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
below 87% of Pharma & Biotech
What changed in the last 30 days
Oct 27Director Manieu Alexandre Weinstein bought $1.3M (Oct 23)

Watch PLUR

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-74.4%12M
-78%-47%-16%+15%2025-102025-122026-022026-042026-062026-082026-10 2026-10-23 · Manieu Alexandre Weinstein bought $1.3M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns PLUR: institutional holders (13F)

13F holdings, latest reported quarter
RENAISSANCE TECHNOLOGIES LLC
18,324 sh
$38.3K
MORGAN STANLEY
2,982 sh
$6.2K
EverSource Wealth Advisors, LLC
2,000 sh
$4.2K
UBS Group AG
1,918 sh
$4.0K
SIMA Wealth Partners, LLC
350 sh
$732

Congress trades in PLUR

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

PLUR planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

PLUR mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Nasdaq Composite Index Fund
$6.4K position · as of 2026-05-31
0.0%
Dimensional International Small Cap ETF
$1 position · as of 2026-07-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 5 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

PLUR financials

Revenue growth
-24.0%
XBRL, annual
Net margin
-2344.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.0M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-2,345%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$20.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
-0.79x
TTM operating cash flow over long-term debt only, 2025-03-31 (15 months older than the period end)
Return on equity
n/a
average equity is zero or negative
Return on assets
-75.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$33.6M
market value at close 2026-10-23 on 2026-09-09 shares, plus long-term debt only, 2025-03-31 (15 months older than the period end), minus cash 2026-06-30
FCF yield
-165.5%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-062025-062024-062023-06
Revenue$1.0M$1.3M$326.0K$287.0K
Gross profit$453.0K$654.0K$322.0K$278.0K
Operating income-$24.9M-$22.2M-$22.2M-$27.2M
Net income-$23.8M-$22.6M$21.3M$28.9M
EPS (diluted)-2.44-3.56-3.99-6.24
Operating cash flow-$19.6M-$18.2M-$18.0M-$22.9M
Cash$3.5M$5.9M$6.8M$5.4M
Long-term debtn/an/a$24.0M$23.5M
SEC XBRL, fiscal years, as known on 2026-10-27

PLUR Stock Sonar score 4/7 axes

Find similar shapesCompare

PLUR ranks highest on financial health (55th percentile) and risk and compliance (49th), and lowest on institutional and government (5th), among Pharma & Biotech peers.

Financial health
55
Inputs
  • Debt to equityequity is zero or negative, the ratio has no meaning
  • Cash flow to debt-0.79x · 55 pct, sector of 371
Growth
29
Inputs
  • Revenue growth, YoY-24.0% · 29 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
5
Inputs
  • Funds adding, latest quarter5 · 5 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
49
Inputs
  • Short interest, % of float+0.3% · 89 pct, sector of 813
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+28.1% · 9 pct, sector of 511
3 not measured: Profitability, Insider conviction, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; pre-tax loss, no effective tax rate to apply
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies